Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
5,625,478 GBP
6,696,493 GBP
Revenue
- GBP
- GBP
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
4,140,059 GBP
6,105,570 GBP
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
1,732 GBP
31,941 GBP
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
3,077,453 GBP
4,449,311 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.